You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
About This Series
Functional gastrointestinal disorders affect approximately 40 million people in the United States, and the toll in terms of burden of disease on individuals and the healthcare system is significant. Patients and clinicians alike are not satisfied with traditional treatment options, and it is hoped that recent and emerging additions to the therapeutic armamentarium will improve outcomes. Taryn Brill hosts this series of expert perspectives by a leader in the field of irritable bowel syndrome, who will explore treatment options for patients with functional disorders of constipation and diarrhea.
Functional gastrointestinal disorders affect approximately 40 million people in the United States, and the toll in terms of burden of disease on individuals and the healthcare system is significant. Patients and clinicians alike are not satisfied with traditional treatment options, and it is hoped that recent and emerging additions to the therapeutic armamentarium will improve outcomes. Taryn Brill hosts this series of expert perspectives by a leader in the field of irritable bowel syndrome, who will explore treatment options for patients with functional disorders of constipation and diarrhea.
Host
Taryn Brill
Medical Journalist,
New York, New York
Faculty
Darren M. Brenner, MD
Associate Professor of Medicine and Surgery
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Supported by an independent educational grant from
Salix Pharmaceuticals, Inc. and Shire